US 11185585
Methods and compositions for improving antiangiogenic therapy with anti-integrins
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11185585 (Methods and compositions for improving antiangiogenic therapy with anti-integrins) held by The Regents of the University of California expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/39558